News from neurovive pharmaceutical A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

20 Dec, 2019, 14:44 GMT NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part...


16 Dec, 2019, 10:21 GMT NeuroVive Announces Settlement in Dispute With CicloMulsion AG

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) announced today that it has fully and finally settled the dispute with CicloMulsion ...


20 Nov, 2019, 08:04 GMT NeuroVive Pharmaceutical AB Interim Report January - September 2019

Important events July - September NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study NeuroSTAT receives Fast Track...


21 Aug, 2019, 07:55 BST NeuroVive Pharmaceutical AB Interim Report January - June 2019

Important events April – June The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling...


27 Jul, 2019, 12:38 BST NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for...


04 Jul, 2019, 13:46 BST NeuroVive Initiates Second Part of its Ongoing KL1333 Phase Ia/b Clinical Study

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has initiated the second part in its ongoing...


21 May, 2019, 07:45 BST NeuroVive Pharmaceutical AB Interim Report January - March 2019

Important events January-March 2019 NeuroVive enrolls first subject in its KL1333 phase Ia/b clinical study. NeuroVive is supplied with approximately ...


10 May, 2019, 07:48 BST NeuroVive's IND for Clinical Development of NeuroSTAT Approved by FDA

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the US Food and Drug Administration, FDA, has approved...


25 Mar, 2019, 09:48 GMT NeuroVive Pharmaceutical AB Publishes 2018 Annual Report

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the English version of the Annual report for 2018 is now...


19 Mar, 2019, 07:51 GMT NeuroVive Enrolls First Subject in its KL1333 Phase Ia/b Clinical Study

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the first healthy volunteer in the company's KL1333 phase Ia/b ...


07 Mar, 2019, 08:07 GMT NeuroVive Receives SEK 28.2 Million in a Directed New Share Issue

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company has successfully conducted a directed new issue...


21 Feb, 2019, 07:52 GMT NeuroVive Enters Commercial Partnership With Oroboros Instruments on Mitochondrial Medicine Research Compounds

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that the company has entered into an exclusive agreement to license ...


15 Nov, 2018, 11:25 GMT NeuroVive Receives Vinnova Funding to Support Development of NV354, a Novel Treatment for Genetic Mitochondrial Disorders

NeuroVive Pharmaceutical AB(Nasdaq Stockholm: NVP, OTCQX: NEVPF) announced today that the company has been awarded SEK 1.5 million as a first tranche ...


31 Oct, 2018, 08:07 GMT NeuroVive Today Announces That the Subscription Period for Warrants of Series 2018:1 Will Begin on Thursday, November 1

NeuroVive Pharmaceutical AB (publ) ("NeuroVive" or "the Company") (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) announces today that the subscription period ...


10 Oct, 2018, 07:41 BST NeuroVive Receives KL1333 Clinical Trial Regulatory Approval

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced that it has received approval of its clinical trial application...


04 Oct, 2018, 07:50 BST NeuroVive Reports First NeuroSTAT Clinical Efficacy Signal in TBI

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the successful completion of biomarker analyses of samples from its ...


06 Sep, 2018, 07:57 BST NeuroVive Receives Positive FDA Feedback on its NeuroSTAT TBI Development Plan

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced positive U.S. Food and Drug Administration (FDA) feedback on its...


28 Aug, 2018, 08:03 BST NeuroVive's NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children's Hospital of Philadelphia

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that scientists at the company's research partner the Children's...


21 Aug, 2018, 08:15 BST NeuroVive Pharmaceutical AB Interim Report January - June 2018

Important events January-June 2018 NeuroVive out-licenses targeted LHON therapy to BridgeBio Pharma's new subsidiary Fortify Therapeutics. The...


18 Jun, 2018, 07:50 BST NeuroVive Out-licenses Targeted LHON Therapy to BridgeBio Pharma's New Subsidiary Fortify Therapeutics

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) and BridgeBio Pharma today jointly announced that BridgeBio has entered into an...


31 May, 2018, 08:15 BST Amended Number of Shares and Votes in NeuroVive Pharmaceutical AB (publ)

euroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF), the mitochondrial medicine company, today announced an increase of the number of...


22 May, 2018, 08:00 BST NeuroVive Pharmaceutical AB Interim Report January - March 2018

Successful rights issue Business operations Important events January – March 2018 NeuroVive decided to conduct a rights issue for the continued...


21 May, 2018, 10:20 BST NeuroVive and Yungjin Reports Positive KL1333 Phase I Clinical Study Results Paving the way for Further Clinical Development

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) and Yungjin Pharm Corporation Ltd (South Korea Stock Market, KRX 003520) today...


02 May, 2018, 08:04 BST NeuroVive Initiates Collaboration With Leading US TBI Research Organization

NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced a partnership with TRACK-TBI, a network of US-based world-leading...


27 Apr, 2018, 13:31 BST Amendment: Resolutions From Annual General Meeting in NeuroVive Pharmaceutical AB (publ)

euroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) ("NeuroVive") today on 27 April 2018 held its Annual General Meeting (AGM). A...